Bjurlin Archives | Page 2 of 3 | Department of Urology

We only need to make a single incision instead of multiple incisions, which typically translates into less post operative pain, and the patient being able to leave the hospital sooner,” says Dr. Bjurlin.

A team of UNC researchers’ work has earned them a coveted spot in the American Urological Association's (AUA) 2023 Annual Meeting Press Program including Hannah E. Kay, MD, UNC Urology 2nd Year Resident

Congratulations to Marc Bjurlin, DO, MSc, and NYU PI Stella Kang, MD, MSc, who have been awarded a National Institute of Health R01 Grant for “Tailored Screening for Urinary System Cancers in Patients with Chronic Kidney Disease.”

Dr. Marc Bjurlin was recently interviewed by Dr. John Davis for the American Urological Association’s podcast, the AUA PUB Stream. On the podcast Drs. Bjurlin discussed his recent work on multiparametric magnetic resonance imaging (mpMRI) and the standard operating procedures for diagnosis, staging, and management of prostate cancer.

The KOELIS® MRI Fusion Biopsy System was brought to UNC by the Prostate Cancer Diagnostic & Treatment Research Program. At the end of April 2022, Dr. Marc Bjurlin performed the first transperineal MRI-Ultrasound fusion prostate biopsies utilizing this new system.

Marc Bjurlin, DO, MSc, FACOS announced as one of the 2021 Clinical Trialist Training Program (CTTP) Scholars

Congratulations to Marc Bjurlin, DO, MSc, FACOS on his recent selection to the AUA's Clinical Trails Education (CTE) Steering Committee.

Congratulations to Marc Bjurlin, DO, MSc, FACOS on his recent selection to lead the Imaging Team, a sub-team of the AUA's New Technologies & Imaging Committee.

Congratulations to Marc Bjurlin, MD along with co-investigators Drs. Rebecca Fry, and William Kim, MD on their recent UNC Lineberger Innovation Award for “Evaluating the carcinogenic effects of electronic cigarettes on the urothelium.”

The second major update we made is there is now sufficient data to support the use of prostate MRI in all men before their initial prostate biopsy when the MRI is of sufficient quality Dr. Bjurlin told Urology Times.

A recently approved funding proposal through NC TraCS and NYU to characterize carcinogenic biomarkers found in the urine of young adult e-cigarette users will soon be underway. The proposal put together by UNC Urologist Dr. Marc Bjurlin, Dr. Ilona Jaspers, and Dr. Terry Gordon hopes to not only better understand the types of bladder cancer-causing biomarkers in e-cigarette user urine, but also strengthen the foundation for future e-cigarette research and regulations.

A recent JAMA publication by UNC Urologist Marc Bjurlin, DO, MSc and two NYU Langone Health Physicians provide evidence to suggest many incidentally discovered small kidney tumors =< 4 cm (AJCC stage T1a) can be managed expectantly without resection because for some patients the risk is greater for mortality from nononcologic causes than from the kidney cancer.

Tag: Bjurlin

UNC’s Advanced Robotic Surgery Tools Provide Less Invasive “Single Port” Procedures For Urology Patients

UNC Urology Researchers’ Abstract Selected for the AUA2023 Annual Meeting Press Program

Bjurlin Member of Research Team Awarded NIH R01 Grant

Bjurlin Featured on AUA’s Podcast About Prostate Cancer and mpMRI

KOELIS® MRI Fusion Biopsy System Introduced at UNC Health

Bjurlin Selected As 2021 Clinical Trialist Training Program Scholar

Dr. Bjurlin Selected For AUA’s Clinical Trials Education Steering Committee

Dr. Bjurlin To Lead Imaging Team in AUA’s New Technologies & Imaging Committee

Drs. Bjurlin, Fry, and Kim Awarded Lineberger Innovation Award for Evaluating the Carcinogenic Effects of E-Cigarettes on the Urothelium

Dr. Marc Bjurlin Leads Team to Publish Updated AUA Policy on the Use of mpMRI with Prostate Cancer Diagnosis and Management

Funding Approved For Pilot Analysis Of Bladder Carcinogens In The Urine Of Young Adult E-Cigarettes Users

Recent JAMA Publication by Bjurlin Suggests Small Kidney Tumors Can Be Managed Without Resection